CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

DexCom rises after raising lower end of 2026 revenue forecast range

By Reuters News

** Shares of DexCom DXCM.O rise 2.6% to $81.97 in extended trading

** The medical device maker expects 2026 revenue between $5.20 billion and $5.25 billion vs its prior range of $5.18 billion to $5.25 billion

** Reports Q3 revenue of $1.34 billion vs analysts' estimate of $1.327 billion - LSEG data

** Company also announced a share repurchase authorization of up to $1 billion

** As of last close, stock up 20.4% YDT

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk